Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to understand if low sodium (cardiac) diet is indeed necessary for better health outcomes in patients who suffered heart failure. This study will investigate the association between sodium intake and risk for 30-day re-admission in Heart Failure (HF) patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Normal Salt Diet | Experimental | 3-4 gm/day salt diet |
|
| Cardiac Diet | Placebo Comparator | 2 gm/day salt diet |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Normal Salt Diet | Other | This study will allow regular diet 3-4 g Na-Salt per day in patients with acute HF as an intervention, because the standard recommendation for such patients is cardiac diet with 2 g Na per day. The intervention will end when the patient is discharged from the hospital. They will follow routine clinical care recommendations after discharge from hospital. |
| Measure | Description | Time Frame |
|---|---|---|
| Length of hospital stay | number of days the patient remains hospitalized | Hospital admission to time of discharge assessed up to 1 year |
| 30-day readmission | readmission to hospital within 30 days of discharge from the index event | 30 days after discharge from hospital after index event |
| NT-proBNP on discharge | Measurement of blood levels of NT-ProBNP a biomarker for diagnosing and assessing the severity of heart failure. | time of hospital admission to 30 days after discharge |
| Loop diuretic requirement during index admission | Furosemide, torsemide, and bumetanide are specific loop diuretics used in the treatment of fluid overload / retention conditions like congestive heart failure. | time of hospital admission to 30 days after discharge |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Maya Guglin, MD | Contact | 8483915776 | maya.guglin@rutgers.edu | |
| Manisha Bajpai, PhD | Contact | manisha.bajpai@rutgers.edu |
| Name | Affiliation | Role |
|---|---|---|
| Maya Guglin, MD | Rutgers University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Robert Wood Johnson Barnabas Hospital - New Brunswick | Recruiting | New Brunswick | New Jersey | 08901 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
All patients with study ID ending in an odd number will be randomized to the Cardiac diet (control arm) and even number to the normal diet (interventional arm).
Not provided
Not provided
Not provided
Not provided
|
| Cardiac Diet | Other | This arm of study will allow the cardiac diet with 2 g Na per day, that is standard recommendation for HF patients. They will follow routine clinical care recommendations after discharge from hospital. |
|